! ORL via Alexandros G.Sfakianakis on Inoreader: Treating prolactinomas with dopamine agonists: always worth the gamble?

! ORL via Alexandros G.Sfakianakis on Inoreader

Treating prolactinomas with dopamine agonists: always worth the gamble? Sep 3rd 2015, 18:27 Abstract Dopamine agonists are the treatment of choice for all patients with prolactinomas. They are generally safe, effective, and well-tolerated. However, a link between their use and the development of impulse control disorders has been well recognized in the field of neurology for some time, and evidence for a similar effect in endocrine patients is emerging. This has mainly been revealed through clinical case reports, plus a small number of comparative studies of varying robustness. We review the current available literature and discuss the implications for clinical practice, in particular emphasizing the need for clinicians to be alert to these uncommon but serious adverse effects.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions